Centre Hospitalier de Saint Brieuc
Saint-Brieuc, Brittany Region, 22000, France
NCT Number: NCT05697666
Neuromuscular blockade (NMB) is proposed in patients with moderate to severe acute respiratory distress syndrome (ARDS). The supposed benefit of these muscle relaxants could be partly linked to their effects on respiratory mechanics by reducing ventilator induced lung injuries (VILI), especially the so called atelectrauma. Although its monitoring is recommended in clinical practice, data about the depth of NMB necessary for an effective relaxation of the thoracic and diaphragmatic muscles and, therefore, the reduction of the chest wall elastance, are scarce. The investigators hypothesised that complete versus partial NMB can modify respiratory mechanics and its partitioning.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Saint-Brieuc, Brittany Region, 22000, France
The investigators conducted a prospective study to compare the respiratory mechanics of patients with moderate to severe ARDS according to the NMB depth, using an oesophageal pressure catheter (NutriVent®, Sidam) for transpulmonary pressure (PL) assessment, and facial train of four (TOF) for neuromuscular blockade monitoring. The oesophageal balloon was calibrated according to the method recently described to estimate the individual target volume which is assumed to be more adequate. Each patient was analysed at two different times: deep NMB (TOF = 0) and intermediate to light NMB (TOF > 0). The mechanical ventilation parameters were identical for these two measurements. The primary endpoint was the proportion of patients with expiratory transpulmonary pressure (PLexp) greater than or equal to 0 according to the NMB level, in order to assess the risk of region-dependent atelectasis and alveolar opening/closing injury (atelectrauma). Secondary endpoints included: the impact of the depth of NMB on other partition parameters of respiratory mechanics, and the variability of results according to the type of oesophageal balloon calibration.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Analysis of the respiratory mechanics at two times:
Time frame: one day
Proportion of patients with expiratory transpulmonary pressure greater than or equal to 0 according to the level of neuromuscular blockade (%)
Time frame: one day
Inspiratory transpulmonary pressure according to the level of neuromuscular blockade (cmH20)
Time frame: one day
Respiratory system compliance according to the level of neuromuscular blockade (ml/cmH20)
Time frame: one day
Chest wall elastance according to the level of neuromuscular blockade (cmH2O/l)
Time frame: one day
Pulmonary elastance according to the level of neuromuscular blockade (cmH2O/l)
Time frame: one day
Driving pressure according to the level of neuromuscular blockade (cmH20)
Time frame: one day
Transpulmonary driving pressure according to the level of neuromuscular blockade (cmH20)
Time frame: one day
Plateau pressure according to the level of neuromuscular blockade (cmH20)
Time frame: one day
Proportion of patients with expiratory transpulmonary pressure greater than or equal to 0 according to the oesophageal balloon calibration volume (%)
Centre Hospitalier de Saint-Brieuc
Other
The Depth of Neuromuscular Blockade is Not Related to Expiratory Transpulmonary Pressure and Respiratory Mechanics in Moderate to Severe ARDS Patients. A Prospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06413472
Acute Respiratory Distress Syndrome, Lung Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04641897
Acute Respiratory Distress Syndrome, Lung Diseases
Santiago, Chile
View Trial DetailsNCT07595926
Acute Respiratory Distress Syndrome, Height
Amiens, France
View Trial DetailsNCT00568659
Acute Lung Injury, Acute Respiratory Distress Syndrome
Milan, Italy
View Trial Details